Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Okan Tezcan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2014
Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cellsOkan Tezcan, Ufuk Gündüz
Cellular Signalling|August 8, 2020
Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cellsSteffen K Meurer, Okan Tezcan, Twan Lammers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2023
Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancerOkan Tezcan, Asmaa Said Elshafei, Karina Benderski, et al.
Science Advances|November 11, 2022
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitizationPradipta Ranjan Rauta, Yuri Mackeyev, Keith Sanders, et al.
Science Advances|March 26, 2025
Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiationOnur Sahin, Yuri Mackeyev, Geraldine V Vijay, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2014
Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cellsOkan Tezcan, Ufuk Gündüz
Cellular Signalling|August 8, 2020
Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cellsSteffen K Meurer, Okan Tezcan, Twan Lammers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2023
Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancerOkan Tezcan, Asmaa Said Elshafei, Karina Benderski, et al.
Science Advances|November 11, 2022
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitizationPradipta Ranjan Rauta, Yuri Mackeyev, Keith Sanders, et al.
Science Advances|March 26, 2025
Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiationOnur Sahin, Yuri Mackeyev, Geraldine V Vijay, et al.
Pageof 1